How to buy Revance The stock
Learn how to easily invest in Revance The stock.
Revance The is a biotechnology business based in the US. Revance The shares (RVNC) are listed on the NASDAQ and all prices are listed in US Dollars. Revance The employs 534 staff and has a trailing 12-month revenue of around $186.4 million.
How to buy Revance The stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RVNC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Revance The stock price (NASDAQ: RVNC)Use our graph to track the performance of RVNC stocks over time.
Revance The shares at a glance
|Latest market close||$12.09|
|52-week range||$11.10 - $37.98|
|50-day moving average||$18.94|
|200-day moving average||$26.86|
|Wall St. target price||$37.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.57|
Buy Revance The stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Revance The stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revance The price performance over time
|1 week (2023-09-21)||-3.05%|
|1 month (2023-08-28)||-33.90%|
|3 months (2023-06-28)||-52.40%|
|6 months (2023-03-28)||-61.48%|
|1 year (2022-09-28)||-51.52%|
|2 years (2021-09-28)||-57.83%|
|3 years (2020-09-28)||25.99|
|5 years (2018-09-28)||24.85|
Revance The financials
|Revenue TTM||$186.4 million|
|Gross profit TTM||$-20,388,000|
|Return on assets TTM||-29.72%|
|Return on equity TTM||-2962.17%|
|Market Capitalization||$1.1 billion|
TTM: trailing 12 months
Revance The share dividends
We're not expecting Revance The to pay a dividend over the next 12 months.
Revance The share price volatility
Over the last 12 months, Revance The's shares have ranged in value from as little as $11.1 up to $37.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Revance The's is 0.8005. This would suggest that Revance The's shares are less volatile than average (for this exchange).
Revance The overview
Revance Therapeutics, Inc. , a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids; and OPUL Relational Commerce Platform, a financial technology platform. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA.
Revance The in the news
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Revance Therapeutics, Inc. - RVNC
3 Healthcare Stocks to Sell in September Before They Crash & Burn
Frequently asked questionsWhat percentage of Revance The is owned by insiders or institutions?
Currently 2.439% of Revance The shares are held by insiders and 97.124% by institutions. How many people work for Revance The?
Latest data suggests 534 work at Revance The. When does the fiscal year end for Revance The?
Revance The's fiscal year ends in December. Where is Revance The based?
Revance The's address is: 1222 Demonbreun Street, Nashville, TN, United States, 37203 What is Revance The's ISIN number?
Revance The's international securities identification number is: US7613301099 What is Revance The's CUSIP number?
Revance The's Committee on Uniform Securities Identification Procedures number is: 761330109
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
How to buy HHGregg IncIN stock
Steps to owning and managing HGGG, with 24-hour and historical pricing before you buy.
Ask an Expert